Literature DB >> 18048710

Posterior reversible encephalopathy syndrome in (low renin) essential hypertension.

C M Everett1, B Turner, M Lobo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 18048710      PMCID： PMC2099403          DOI： 10.1177/014107680710001115

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   5.344


× No keyword cloud information.
  8 in total

1.  Pontine reversible edema: a newly recognized imaging variant of hypertensive encephalopathy?

Authors:  S O Casey; C L Truwit
Journal:  AJNR Am J Neuroradiol       Date:  2000-02       Impact factor: 3.825

Review 2.  Reversible posterior leukoencephalopathy syndrome: a misnomer reviewed.

Authors:  V L Stott; M A Hurrell; T J Anderson
Journal:  Intern Med J       Date:  2005-02       Impact factor: 2.048

Review 3.  Cerebral autoregulation.

Authors:  O B Paulson; S Strandgaard; L Edvinsson
Journal:  Cerebrovasc Brain Metab Rev       Date:  1990

Review 4.  Hypertensive emergencies.

Authors:  C J Vaughan; N Delanty
Journal:  Lancet       Date:  2000-07-29       Impact factor: 79.321

5.  Eclamptic encephalopathy: imaging and pathogenetic considerations.

Authors:  M Manfredi; A Beltramello; L G Bongiovanni; A Polo; L Pistoia; N Rizzuto
Journal:  Acta Neurol Scand       Date:  1997-11       Impact factor: 3.209

6.  Clinical spectrum of reversible posterior leukoencephalopathy syndrome.

Authors:  S Kwon; J Koo; S Lee
Journal:  Pediatr Neurol       Date:  2001-05       Impact factor: 3.372

7.  A reversible posterior leukoencephalopathy syndrome.

Authors:  J Hinchey; C Chaves; B Appignani; J Breen; L Pao; A Wang; M S Pessin; C Lamy; J L Mas; L R Caplan
Journal:  N Engl J Med       Date:  1996-02-22       Impact factor: 91.245

8.  Involvement of the central nervous system in renal hypertension.

Authors:  K Schärer; C Benninger; A Heimann; W Rascher
Journal:  Eur J Pediatr       Date:  1993-01       Impact factor: 3.183
  8 in total
  1 in total

1.  Calcimimetic R568 reduced the blood pressure and improved aortic remodeling in spontaneously hypertensive rats by inhibiting local renin-angiotensin system activity.

Authors:  Ruixia Sun; Wenwen Zhang; Hua Zhong; Lamei Wang; Na Tang; Yongmin Liu; Yongli Zhao; Tian Zhang; Fang He
Journal:  Exp Ther Med       Date:  2018-09-13       Impact factor: 2.447
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.